Eli Lilly Captures Majority of GLP-1 Market with Mounjaro Revenue Growth
Eli Lilly (LLY) has captured 60% of the GLP-1 market as its drug Mounjaro's revenue surged by 125%, reaching $8.66 billion in Q1 2026. The company reported total quarterly revenue of $19.80 billion, a 55.5% year-over-year increase, and raised full-year guidance to between $82.0B-$85.0B.
Topics: GLP-1 market Mounjaro revenue growth pharma industry dominance Q1 earnings report